These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2288838

  • 1. Use of Emax model in diuretic studies.
    Noormohamed FH.
    Br J Clin Pharmacol; 1990 Dec; 30(6):907-8. PubMed ID: 2288838
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Optimal way of administration of high dose intravenous furosemide - continuous infusion or bolus?].
    Gallusová J, Halačová M, Cerný D.
    Vnitr Lek; 2014 Oct; 60(10):885-92. PubMed ID: 25382011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of route of administration on the relative efficacy and potency of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol HCl (MK447) and furosemide.
    Johnston PA, Leszczynska K, Yochim C, Kau ST.
    Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):481-6. PubMed ID: 2087148
    [Abstract] [Full Text] [Related]

  • 7. Gastrointestinal first-pass effect of furosemide in rats.
    Kim EJ, Han KS, Lee MG.
    J Pharm Pharmacol; 2000 Nov; 52(11):1337-43. PubMed ID: 11186241
    [Abstract] [Full Text] [Related]

  • 8. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P.
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [Abstract] [Full Text] [Related]

  • 9. [How can improved effectiveness of the loop diuretic furosemide be explained when the same dosage is administered 2 x daily (morning and noon)?].
    Steffgen J.
    Internist (Berl); 1996 Apr; 37(4):400-1. PubMed ID: 8655279
    [No Abstract] [Full Text] [Related]

  • 10. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC.
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [Abstract] [Full Text] [Related]

  • 11. Variable furosemide absorption and poor predictability of response in elderly patients.
    Murray MD, Haag KM, Black PK, Hall SD, Brater DC.
    Pharmacotherapy; 1997 Jun; 17(1):98-106. PubMed ID: 9017769
    [Abstract] [Full Text] [Related]

  • 12. Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.
    Dirikolu L, Lehner AF, Hughes C, Karpiesiuk W, Camargo FC, Harkins JD, Woods WE, Bosken JM, Boyles J, Troppmann A, Fisher M, Tobin T.
    Vet Ther; 2003 Jun; 4(4):350-63. PubMed ID: 15136977
    [Abstract] [Full Text] [Related]

  • 13. Formulation and in vitro examination of furosemide containing suppositories and preliminary experiences of their clinical use.
    Regdon G, Fazekas T, Regdon G, Selmeczi B.
    Pharmazie; 1996 Feb; 51(2):116-9. PubMed ID: 8720807
    [Abstract] [Full Text] [Related]

  • 14. Does it make sense to administer albumin to the patient with nephrotic oedema?
    Dorhout Mees EJ.
    Nephrol Dial Transplant; 1996 Jul; 11(7):1224-6. PubMed ID: 8672009
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.
    Wakelkamp M, Alván G, Gabrielsson J, Paintaud G.
    Clin Pharmacol Ther; 1996 Jul; 60(1):75-88. PubMed ID: 8689815
    [Abstract] [Full Text] [Related]

  • 16. Enhanced absorption of oral furosemide by bile juice in rats.
    Kim EJ, Han KS, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1999 Jul; 104(1):107-10. PubMed ID: 10604283
    [Abstract] [Full Text] [Related]

  • 17. Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
    Brater DC, Chalasani N, Gorski JC, Horlander JC, Craven R, Hoen H, Maya J.
    Trans Am Clin Climatol Assoc; 2001 Jul; 112():108-15; discussion 116. PubMed ID: 11413770
    [No Abstract] [Full Text] [Related]

  • 18. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH, Choi YH, Lee U, Lee JH, Lee MG.
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [Abstract] [Full Text] [Related]

  • 19. The efficiency concept in pharmacodynamics.
    Alván G, Paintaud G, Wakelkamp M.
    Clin Pharmacokinet; 1999 May; 36(5):375-89. PubMed ID: 10384860
    [Abstract] [Full Text] [Related]

  • 20. Furosemide continuous rate infusion diluted with 5% dextrose in water or hypertonic saline in normal adult dogs: a pilot study.
    Adin D, Atkins C, Papich M, DeFrancesco T, Griffiths E, Penteado M, Kurtz K, Klein A.
    J Vet Cardiol; 2017 Feb; 19(1):44-56. PubMed ID: 27840084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.